













BY-O1A
An ophthalmic examination device
BaiYiHealthcare Technology Co.,Ltd
BY-O1A is an ophthalmic examination device designed for thyroid-associated ophthalmopathy. It utilizes real-time data analysis, AI diagnosis, various imaging techniques, and personalized medical advice technology to achieve multifactorial and precise detection of ocular lesions, enhancing diagnostic accuracy and efficiency. With cloud storage and network connection, it enhances data integrity, security, and sharing. Upgrades and maintenance allow the device to be consistently effective and efficient.
Client / ManufacturerDesign
BaiYiHealthcare Technology Co.,Ltd
Shanghai, CNBaiYiHealthcare Technology Co.,Ltd
Shanghai, CNTian Chaonan, Du Dong, Xiong MengyingjingShanghai Institute of Endocrine and Metabolic Diseases
Shanghai, CNWang Weiqing, Shen LiyunDate of Launch
2024
Development Time
up to 6 Month
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Consumers / Users